Пуерто Рико
High income
- Общ преглед
- РазпроÑтранение на затлъÑÑ‚Ñването
- Разбивки на наÑелението
- Причини
- СъпътÑтващи заболÑваниÑ
- Политики
- Contextual factors
Зареждане на данни. Изчакайте...
Ðационален риÑк от затлъÑÑ‚Ñване *8/10This is a composite ‘obesity risk’ score (out of 10, the highest risk) based on obesity prevalence, rate of increase, likelihood of meeting the 2025 target, treatment indicator and childhood stunting levels.РиÑк от затлъÑÑ‚Ñване в детÑка възраÑÑ‚ *4/11This is a ‘risk score’ for each country’s likelihood of having or acquiring a major childhood obesity problem during the 2020s, taking account of current prevalence levels and risk for future obesity (based on stunting among infants, maternal obesity, maternal smoking, and breastfeeding rates).
Report cards
Our report cards collate all the most-recent graphics for this country. If you would like to produce a custom report based on selected graphics, just tap the Add to custom PDF button below the graphics you would like to use.
Разбивки на наÑелението
Причини
ÐедоÑтатъчна активноÑÑ‚
КонÑÑƒÐ¼Ð°Ñ†Ð¸Ñ Ð½Ð° плодове
КонÑÑƒÐ¼Ð°Ñ†Ð¸Ñ Ð½Ð° преработено меÑо
КонÑÑƒÐ¼Ð°Ñ†Ð¸Ñ Ð½Ð° зърнени култури
ДепреÑиÑ
ТревожноÑÑ‚
Причини за затлъÑÑ‚Ñването »
Like all chronic diseases, the root causes/drivers of obesity are complex. Select here to view 'other' root causes/drivers.ИзтеглÑне на карта за отчитане
СъпътÑтващи заболÑваниÑ
Рак на хранопровода
Рак на гърдата
Колоректален рак
Рак на панкреаÑа
Рак на Ð¶Ð»ÑŠÑ‡Ð½Ð¸Ñ Ð¼ÐµÑ…ÑƒÑ€
Рак на бъбреците
Рак на матката
Преобладаване на диабета
Ovarian Cancer
Leukemia
Liver & bile duct cancer
Mulitple Myeloma
Non Hodgkin Lymphoma
Thyroid Cancer
ИзтеглÑне на карта за отчитане
Политики
Contextual factors
РазпроÑтранение на затлъÑÑ‚Ñването
ВъзраÑтни, 2023
| Тип анкета: | Самоотчитане |
| ВъзраÑÑ‚: | 18+ |
| КоличеÑтво на пробите: | 4427 |
| Обхваната зона: | Ðационално |
| Референции: | Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Population Health. BRFSS Prevalence & Trends Data [online]. 2025. [accessed Mon, 17 Nov 2025]. URL: https://www.cdc.gov/brfss/brfssprevalence/. |
| ОÑвен ако не е поÑочено друго, наднорменото тегло Ñе отнаÑÑ Ð´Ð¾ ИТМ между 25 kg и 29,9°kg/m², затлъÑÑ‚Ñването Ñе отнаÑÑ Ð´Ð¾ ИТМ, по-голÑм от 30°. | |
Деца, 2010-2011
| Тип анкета: | Измерено |
| ВъзраÑÑ‚: | 12 |
| КоличеÑтво на пробите: | 1582 |
| Референции: | Elías-Boneta AR, Toro MJ, Garcia O, Torres R, Palacios C. High prevalence of overweight and obesity among a representative sample of Puerto Rican children. BMC Public Health. 2015 Mar 5;15:219. doi: 10.1186/s12889-015-1549-0. PMID: 25885462; PMCID: PMC4358900. Available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4358900/ (last accessed 09.03.22) |
| Забележки: | A probabilistic sample of 133 schools was selected from a total of 1,843 schools. Ten boys and ten girls were randomly selected from each school using the official student lists provided by the school’s administration. The required sample size was 2,600 children. A total of 1,734 children were contacted and invited to participate, however, some of the selected schools were inactive and others had merged. 152 children were excluded due to school absences and failure to obtain their parent’s written consent. |
| ОпределениÑ: | Children were categorized as overweight, or obese using the Center for Disease Control and Prevention's age and gender specific growth charts. |
| Cutoffs: | CDC |
Ðаднормено тегло/затлъÑÑ‚Ñване по образование
ВъзраÑтни, 2023
| Тип анкета: | Самоотчитане |
| ВъзраÑÑ‚: | 18+ |
| КоличеÑтво на пробите: | 4427 |
| Обхваната зона: | Ðационално |
| Референции: | Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Population Health. BRFSS Prevalence & Trends Data [online]. 2025. [accessed Mon, 17 Nov 2025 13:34:31 GMT]. URL: https://www.cdc.gov/brfss/brfssprevalence/. |
| ОÑвен ако не е поÑочено друго, наднорменото тегло Ñе отнаÑÑ Ð´Ð¾ ИТМ между 25 kg и 29,9°kg/m², затлъÑÑ‚Ñването Ñе отнаÑÑ Ð´Ð¾ ИТМ, по-голÑм от 30°. | |
ВъзраÑтни, 2005-2007
| Тип анкета: | Измерено |
| ВъзраÑÑ‚: | 45-52 |
| КоличеÑтво на пробите: | 840 |
| Обхваната зона: | Regional - San Juan Metropolitan Area |
| Референции: | Prevalence of overweight and obesity and their cardiometabolic comorbidities in Hispanic adults living in San Juan Metropolitan Area, Puerto Rico https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823746/ (last accessed 09.03.22) |
| ОÑвен ако не е поÑочено друго, наднорменото тегло Ñе отнаÑÑ Ð´Ð¾ ИТМ между 25 kg и 29,9°kg/m², затлъÑÑ‚Ñването Ñе отнаÑÑ Ð´Ð¾ ИТМ, по-голÑм от 30°. | |
Ðаднормено тегло/затлъÑÑ‚Ñване по възраÑÑ‚
ВъзраÑтни, 2023
| Тип анкета: | Самоотчитане |
| КоличеÑтво на пробите: | 4427 |
| Обхваната зона: | Ðационално |
| Референции: | Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Population Health. BRFSS Prevalence & Trends Data [online]. 2025. [accessed Mon, 17 Nov 2025 13:34:31 GMT]. URL: https://www.cdc.gov/brfss/brfssprevalence/. |
| ОÑвен ако не е поÑочено друго, наднорменото тегло Ñе отнаÑÑ Ð´Ð¾ ИТМ между 25 kg и 29,9°kg/m², затлъÑÑ‚Ñването Ñе отнаÑÑ Ð´Ð¾ ИТМ, по-голÑм от 30°. | |
ВъзраÑтни, 2005-2007
| Тип анкета: | Измерено |
| КоличеÑтво на пробите: | 840 |
| Обхваната зона: | Regional - San Juan Metropolitan Area |
| Референции: | Prevalence of overweight and obesity and their cardiometabolic comorbidities in Hispanic adults living in San Juan Metropolitan Area, Puerto Rico https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823746/ (last accessed 09.03.22) |
| ОÑвен ако не е поÑочено друго, наднорменото тегло Ñе отнаÑÑ Ð´Ð¾ ИТМ между 25 kg и 29,9°kg/m², затлъÑÑ‚Ñването Ñе отнаÑÑ Ð´Ð¾ ИТМ, по-голÑм от 30°. | |
Ðаднормено тегло/затлъÑÑ‚Ñване по Ñоциално-икономичеÑка група
ВъзраÑтни, 2023
| Тип анкета: | Самоотчитане |
| ВъзраÑÑ‚: | 18+ |
| КоличеÑтво на пробите: | 4427 |
| Обхваната зона: | Ðационално |
| Референции: | Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Population Health. BRFSS Prevalence & Trends Data [online]. 2025. [accessed Mon, 17 Nov 2025 13:34:31 GMT]. URL: https://www.cdc.gov/brfss/brfssprevalence/. |
| Забележки: | Insufficient sample size for those with income $200,000+ |
| ОÑвен ако не е поÑочено друго, наднорменото тегло Ñе отнаÑÑ Ð´Ð¾ ИТМ между 25 kg и 29,9°kg/m², затлъÑÑ‚Ñването Ñе отнаÑÑ Ð´Ð¾ ИТМ, по-голÑм от 30°. | |
Double burden of underweight & overweight
ВъзраÑтни, 2022
| Тип анкета: | Измерено |
| ВъзраÑÑ‚: | 20+ |
| Референции: | NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population representative studies with 222 million children, adolescents, and adults. Lancet 2024; published online Feb 29. https://doi.org/10.1016/S0140-6736(23)02750-2. |
| Забележки: | Age Standardised estimates |
| ОпределениÑ: | Combined prevalence of BMI<18.5 kg/m² and BMI>=30 kg/m² (double burden of underweight and obesity) |
Деца, 2022
| Тип анкета: | Измерено |
| ВъзраÑÑ‚: | 5-19 |
| Референции: | NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population representative studies with 222 million children, adolescents, and adults. Lancet 2024; published online Feb 29. https://doi.org/10.1016/S0140-6736(23)02750-2. |
| Забележки: | Age standardised estimates |
| ОпределениÑ: | Combined prevalence of BMI < -2SD and BMI > 2SD (double burden of thinness and obesity) |
| Cutoffs: | BMI < -2SD and BMI > 2SD |
ÐедоÑтатъчна физичеÑка активноÑÑ‚
ВъзраÑтни, 2022
| Тип анкета: | Самоотчитане |
| ВъзраÑÑ‚: | 18+ |
| Обхваната зона: | Ðационално |
| Референции: | WHO (2024). Prevalence of insufficient physical activity among adults aged 18-years age-standardized estimate in 2022. Available at https://www.who.int/data/gho/data/indicators/indicator-details/GHO/prevalence-of-insufficient-physical-activity-among-adults-aged-18-years-(age-standardized-estimate)-(-) |
| ОпределениÑ: | Percent of population attaining less than 150 minutes of moderate-intensity physical activity per week, or less than 75 minutes of vigorous-intensity physical activity per week, or equivalent. |
Мъже, 2022
| Тип анкета: | Самоотчитане |
| ВъзраÑÑ‚: | 18+ |
| Обхваната зона: | Ðационално |
| Референции: | WHO (2024). Prevalence of insufficient physical activity among adults aged 18-years age-standardized estimate in 2022. Available at https://www.who.int/data/gho/data/indicators/indicator-details/GHO/prevalence-of-insufficient-physical-activity-among-adults-aged-18-years-(age-standardized-estimate)-(-) |
| ОпределениÑ: | Percent of population attaining less than 150 minutes of moderate-intensity physical activity per week, or less than 75 minutes of vigorous-intensity physical activity per week, or equivalent. |
Жени, 2022
| Тип анкета: | Самоотчитане |
| ВъзраÑÑ‚: | 18+ |
| Обхваната зона: | Ðационално |
| Референции: | WHO (2024). Prevalence of insufficient physical activity among adults aged 18-years age-standardized estimate in 2022. Available at https://www.who.int/data/gho/data/indicators/indicator-details/GHO/prevalence-of-insufficient-physical-activity-among-adults-aged-18-years-(age-standardized-estimate)-(-) |
| ОпределениÑ: | Percent of population attaining less than 150 minutes of moderate-intensity physical activity per week, or less than 75 minutes of vigorous-intensity physical activity per week, or equivalent. |
Estimated per capita fruit intake
ВъзраÑтни, 2017
| ВъзраÑÑ‚: | 25+ |
| Обхваната зона: | Ðационално |
| Референции: | Global Burden of Disease, the Institute for Health Metrics and Evaluation http://ghdx.healthdata.org/ |
| ОпределениÑ: | Estimated per capita fruit intake (g/day) |
Estimated per capita processed meat intake
ВъзраÑтни, 2017
| ВъзраÑÑ‚: | 25+ |
| Обхваната зона: | Ðационално |
| Референции: | Global Burden of Disease, the Institute for Health Metrics and Evaluation http://ghdx.healthdata.org/ |
| ОпределениÑ: | Estimated per capita processed meat intake (g per day) |
Estimated per capita whole grains intake
ВъзраÑтни, 2017
| Тип анкета: | Измерено |
| ВъзраÑÑ‚: | 25+ |
| Референции: | Global Burden of Disease, the Institute for Health Metrics and Evaluation http://ghdx.healthdata.org/ |
| ОпределениÑ: | Estimated per-capita whole grains intake (g/day) |
ПÑихично здраве – депреÑивни разÑтройÑтва
ВъзраÑтни, 2021
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25) |
| ОпределениÑ: | Number living with depression per 100,000 population (adults 20+ years) |
Мъже, 2021
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25) |
| ОпределениÑ: | Number living with depression per 100,000 population (adults 20+ years) |
Жени, 2021
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25) |
| ОпределениÑ: | Number living with depression per 100,000 population (adults 20+ years) |
Деца, 2021
| Обхваната зона: | Ðационално |
| Референции: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25) |
| ОпределениÑ: | Number living with depressive disorder per 100,000 population (Under 20 years of age) |
Момчета, 2021
| Обхваната зона: | Ðационално |
| Референции: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25) |
| ОпределениÑ: | Number living with depressive disorder per 100,000 population (Under 20 years of age) |
Момичета, 2021
| Обхваната зона: | Ðационално |
| Референции: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25) |
| ОпределениÑ: | Number living with depressive disorder per 100,000 population (Under 20 years of age) |
ПÑихично здраве – тревожни разÑтройÑтва
ВъзраÑтни, 2021
| ВъзраÑÑ‚: | 20+ |
| Референции: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25). |
| ОпределениÑ: | Number living with anxiety per 100,000 population |
Мъже, 2021
| ВъзраÑÑ‚: | 20+ |
| Референции: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25). |
| ОпределениÑ: | Number living with anxiety per 100,000 population |
Жени, 2021
| ВъзраÑÑ‚: | 20+ |
| Референции: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25). |
| ОпределениÑ: | Number living with anxiety per 100,000 population |
Деца, 2021
| Референции: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25) |
Момчета, 2021
| Референции: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25) |
Момичета, 2021
| Референции: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25) |
Рак на хранопровода
Мъже, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Indicence per 100,000 |
Жени, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Indicence per 100,000 |
Мъже, 2020
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2289 |
| ОпределениÑ: | Age-standardized indicence rates per 100 000 |
Жени, 2020
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2289 |
| ОпределениÑ: | Age-standardized indicence rates per 100 000 |
Рак на гърдата
Жени, 2022
| ВъзраÑÑ‚: | 20 |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
Колоректален рак
Мъже, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
Жени, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
Мъже, 2020
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2289 |
| ОпределениÑ: | Age-standardized indicence rates per 100 000 |
Жени, 2020
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2289 |
| ОпределениÑ: | Age-standardized indicence rates per 100 000 |
Рак на панкреаÑа
Мъже, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
Жени, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
Мъже, 2020
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2289 |
| ОпределениÑ: | Age-standardized indicence rates per 100 000 |
Жени, 2020
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2289 |
| ОпределениÑ: | Age-standardized indicence rates per 100 000 |
Рак на Ð¶Ð»ÑŠÑ‡Ð½Ð¸Ñ Ð¼ÐµÑ…ÑƒÑ€
Мъже, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Indicence per 100,000 |
Жени, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Indicence per 100,000 |
Мъже, 2020
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2289 |
| ОпределениÑ: | Age-standardized indicence rates per 100 000 |
Жени, 2020
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2289 |
| ОпределениÑ: | Age-standardized indicence rates per 100 000 |
Рак на бъбреците
Мъже, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
Жени, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
Мъже, 2020
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2289 |
| ОпределениÑ: | Age-standardized indicence rates per 100 000 |
Жени, 2020
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2289 |
| ОпределениÑ: | Age-standardized indicence rates per 100 000 |
Рак на матката
Жени, 2022
| ВъзраÑÑ‚: | 20+ |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
Жени, 2020
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2289 |
| ОпределениÑ: | Age-standardized indicence rates per 100 000 |
Преобладаване на диабета
ВъзраÑтни, 2024
| Референции: | Reproduced with kind permission International Diabetes Federation. IDF Diabetes Atlas, 11th edn. Brussels, Belgium:International Diabetes Federation, 2025. http://www.diabetesatlas.org |
ВъзраÑтни, 2021
| ВъзраÑÑ‚: | 20-79 |
| Обхваната зона: | Ðационално |
| Референции: | Reproduced with kind permission International Diabetes Federation. IDF Diabetes Atlas, 10th edn. Brussels, Belgium:International Diabetes Federation, 2021. http://www.diabetesatlas.org |
| ОпределениÑ: | Age-adjusted comparative prevalence of diabetes, % |
ВъзраÑтни, 2019
| ВъзраÑÑ‚: | 20-79 |
| Референции: | Reproduced with kind permission International Diabetes Federation. IDF Diabetes Atlas, 9th edn. Brussels,Belgium: 2019. Available at: https://www.diabetesatlas.org |
| ОпределениÑ: | Diabetes age-adjusted comparative prevalence (%). |
ВъзраÑтни, 2017
| Референции: | Reproduced with kind permission of IDF, International Diabetes Federation. IDF Diabetes Atlas, 8th edition. Brussels, Belgium: International Diabetes Federation, 2017. http://www.diabetesatlas.org |
| ОпределениÑ: | Diabetes age-adjusted comparative prevalence (%). |
Ovarian Cancer
Жени, 2022
| ВъзраÑÑ‚: | 20+ |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
Leukemia
Мъже, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
| ОÑвен ако не е поÑочено друго, наднорменото тегло Ñе отнаÑÑ Ð´Ð¾ ИТМ между 25 kg и 29,9°kg/m², затлъÑÑ‚Ñването Ñе отнаÑÑ Ð´Ð¾ ИТМ, по-голÑм от 30°. | |
Жени, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
| ОÑвен ако не е поÑочено друго, наднорменото тегло Ñе отнаÑÑ Ð´Ð¾ ИТМ между 25 kg и 29,9°kg/m², затлъÑÑ‚Ñването Ñе отнаÑÑ Ð´Ð¾ ИТМ, по-голÑм от 30°. | |
Liver and intrahepatic bile duct Cancer
Мъже, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
Жени, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
Multiple Myeloma
Мъже, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Indicence per 100,000 |
| ОÑвен ако не е поÑочено друго, наднорменото тегло Ñе отнаÑÑ Ð´Ð¾ ИТМ между 25 kg и 29,9°kg/m², затлъÑÑ‚Ñването Ñе отнаÑÑ Ð´Ð¾ ИТМ, по-голÑм от 30°. | |
Жени, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Indicence per 100,000 |
| ОÑвен ако не е поÑочено друго, наднорменото тегло Ñе отнаÑÑ Ð´Ð¾ ИТМ между 25 kg и 29,9°kg/m², затлъÑÑ‚Ñването Ñе отнаÑÑ Ð´Ð¾ ИТМ, по-голÑм от 30°. | |
Non Hodgkin Lymphoma
Мъже, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
| ОÑвен ако не е поÑочено друго, наднорменото тегло Ñе отнаÑÑ Ð´Ð¾ ИТМ между 25 kg и 29,9°kg/m², затлъÑÑ‚Ñването Ñе отнаÑÑ Ð´Ð¾ ИТМ, по-голÑм от 30°. | |
Жени, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
| ОÑвен ако не е поÑочено друго, наднорменото тегло Ñе отнаÑÑ Ð´Ð¾ ИТМ между 25 kg и 29,9°kg/m², затлъÑÑ‚Ñването Ñе отнаÑÑ Ð´Ð¾ ИТМ, по-голÑм от 30°. | |
Thyroid Cancer
Мъже, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
Жени, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
Policies, Interventions and Actions
Contextual factors
Disclaimer: These contextual factors should be interpreted with care. Results are updated as regularly as possible and use very specific criteria. The criteria used and full definitions are available for download at the bottom of this page.
Tap on a tick to find out more about policies influencing this factor.
Labelling
| Is there mandatory nutrition labelling? | Absent |
| Front-of-package labelling? | Absent |
| Back-of-pack nutrition declaration? | Absent |
| Color coding? | Absent |
| Warning label? | Absent |
Regulation and marketing
| Are there fiscal policies on unhealthy products? | Absent |
| Tax on unhealthy foods? | Absent |
| Tax on unhealthy drinks? | Absent |
| Are there fiscal policies on healthy products? | Absent |
| Subsidy on fruits? | Absent |
| Subsidy on vegetables? | Absent |
| Subsidy on other healthy products? | Absent |
| Mandatory limit or ban of trans fat (all settings)? | Present |
| Mandatory limit of trans fats in place (all settings)? | Absent |
| Ban on trans-fats or phos in place (all settings)? | Present |
| Are there any mandatory policies/marketing restrictions on the promotion of unhealthy food/drinks to children? | Absent |
| Mandatory restriction on broadcast media? | Absent |
| Mandatory restriction on non-broadcast media? | Absent |
| Voluntary policies/marketing restrictions on the promotion of unhealthy food/drinks to children? | Absent |
| Are there mandatory standards for food in schools? | Absent |
| Are there any mandatory nutrient limits in any manufactured food products? | Absent |
| Nutrition standards for public sector procurement? | Absent |
Political will and support
| National obesity strategy or nutrition and physical activity national strategy? | Absent |
| National obesity strategy? | Absent |
| National childhood obesity strategy? | Absent |
| Comprehensive nutrition strategy? | Absent |
| Comprehensive physical activity strategy? | Absent |
| Evidence-based dietary guidelines and/or RDAs? | Absent |
| National target(s) on reducing obesity? | Absent |
| Promotion of breastfeeding? | Absent |
Monitoring and surveillance
| Monitoring of the prevalence and incidence for the main obesity-related NCDs and risk factors? | Present |
| Within 5 years? | Absent |
Governance and resource
| Multi-sectoral national co-ordination mechanism for obesity or nutrition (including obesity)? | Absent |
Key
Present
Present (voluntary)
Incoming
Absent
Unknown
Last updated November 27, 2022
Download contextual factors as a PDF Contextual factors definitions
